Stockholders' Equity Note Disclosure [Text Block] | 9. Share Capital The Company’s common shares outstanding are no par value, voting shares with no preferences or rights attached to them. Common shares On January 17, 2017, the Company issued 100,000 shares for a total of $59 as finder fees which were recognized in general and administrative expenses in connection with the declaration of commercial production in December 2016. On February 22, 2018, the Company closed a rights offering and issued 188,952,761 shares for total gross proceeds of $25,036. The Company paid associated fees of $668 which were classified as share issue costs. Stock options The Company’s current stock option plan (the “Plan”) was adopted by the Company in 2013 and approved by shareholders of the Company in 2013. The Plan provides a fixed number of 7,200,000 common shares of the Company that may be issued pursuant to the grant of stock options. The exercise price of stock options granted under the Plan shall be determined by the Company’s Board of Directors (the “Board”) but shall not be less than the volume-weighted, average trading price of the Company’s shares on the Toronto Stock Exchange (“TSX”) for the five (5) trading days immediately prior to the date of the grant. The expiry date of a stock option shall be the date so fixed by the Board subject to a maximum term of five (5) years. The Company has elected to use the Black-Scholes option pricing model to determine the fair value of stock options granted. The compensation expense is amortized on a straight-line basis over the requisite service period, which approximates the vesting period. The following is a summary of stock option activity during the six months ended June 30, 2018: Shares Weighted Average Exercise Price per Share Options outstanding, December 31, 2016 1,555,000 $ 0.85 Options granted 1,605,001 $ 0.38 Options forfeited (166,667 ) $ 0.64 Options expired (393,333 ) $ 1.13 Options outstanding, December 31, 2017 2,600,001 $ 0.54 Options forfeited (75,000 ) $ 0.29 Options expired (50,000 ) $ 1.16 Options outstanding, June 30, 2018 2,475,001 $ 0.53 On March 14, 2017, the former CFO of the Company resigned. 146,667 stock options were forfeited on this date as they did not meet the vesting conditions. Accordingly, the share-based compensation associated with the unvested stock options was reversed. The expiry date of 393,333 stock options that had vested was modified to June 14, 2017 pursuant to the terms of the employment agreement. These stock options were not exercised, thus expired during the year ended December 31, 2017. On March 20, 2017, the Company granted 400,002 options to the Company’s new Chief Financial Officer (“CFO”) which are exercisable at a price of $0.65 for a period of five years from the date of grant. 133,334 options vested on March 20, 2018, 133,334 options vest on March 20, 2019 and 133,334 options vest on March 20, 2020. The fair value of stock options granted as above was calculated using the following weighted average assumptions: 2017 Expected life (years) 5.00 Interest rate 1.18% ~ 1.70 % Volatility 77.29% ~ 79.17 % Dividend yield 0.00 % During the three and six months ended June 30, 2018, the Company recognized $35 and $80 (the three and six months ended June 30, 2017 - $52 and $85) in stock-based compensation relating to employee stock options that were issued and/or had vesting terms. The following table summarizes information about stock options outstanding and exercisable as at June 30, 2018: Expiry Number Number Remaining Exercise September 3, 2018 150,000 150,000 0.18 $ 1.59 September 8, 2020 430,000 430,000 2.19 $ 0.58 November 30, 2021 365,000 121,666 3.42 $ 0.66 March 20, 2022 400,002 133,334 3.72 $ 0.65 October 20, 2022 1,129,999 - 4.31 $ 0.29 Balance, June 30, 2018 2,475,001 835,000 3.47 As at June 30, 2018, the aggregate intrinsic value of the outstanding exercisable options was $nil (December 31, 2017 – Warrants As at June 30, 2018, 24,317,700 warrants were outstanding (December 31, 2017 – 24,317,700). The following table summarizes information about share purchase warrants outstanding: Expiry Number Remaining Exercise June 8, 2020 10,000,000 2.19 $ 0.7831 July 25, 2019 (1) 6,317,700 1.32 C $ 2.0000 November 18, 2021 8,000,000 3.64 $ 0.6650 Balance, June 30, 2018 24,317,700 2.44 (1) Non-tradable share purchase warrants. |